Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05388123
Title Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Scripps Health
Indications

hairy cell leukemia

Therapies

Rituximab + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST